MUMBAI, India, Feb ...

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced ...

Lupin Limited, a global pharmaceutical leader, has achieved an 'A' leadership rating from the Climate Disclosure Project (CDP ...

Lupin introduces topiramate extended-release capsules in US market: Our Bureau, Mumbai Thursday, February 5, 2026, 12:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announ ...

Mumbai: Pharma major Lupin Limited has announced a strategic collaboration with TB Alliance, a nonprofit drug developer, to ...

According to Axis Securities, the reduction in reciprocal taxes is incrementally positive for Indian pharmaceutical companies, particularly those with significant exposure to the US market, ...

Global pharmaceutical firm Lupin will expand its Florida operations with a a new manufacturing plant in Coral Springs. With a projected cumulative investment of $250 million, including research & ...

A leading drugmaker is embroiled in a legal battle with a biopharmaceutical startup, with each claiming the other has stolen trade secrets related to generic inhalers for asthma and other chronic ...

Mumbai: Global pharma major Lupin Limited has announced the launch of Dasatinib Tablets in strengths of 20 mg, 50 mg, 70 mg, ...

Lupin partners with TB Alliance to develop and commercialize Telacebec for treating tuberculosis and related diseases globally.

As per the arrangement, Galenicum will be responsible for the development, manufacturing and supply of finished formulations of injectable Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor ...

Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada DENVER, CO / ACCESSWIRE / ...